Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D3003
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 913 $7,196,235 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $7,196,235 Current and potential, with all options
- Last date to order 84% complete
- IDV ceiling 1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award SPE2DR25D3003 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as medical supplies and equipment, to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies. The IDC has a 30-month base period and three 30-month option periods, for a total potential period of performance through December 2026.
The original solicitation, a pre-solicitation for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), indicates that DLA Troop Support plans to make multiple primary supplier awards for separate geographic regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) as well as a single backup supplier award. The acquisition is unrestricted and fully competitive, with awards made on a lowest price technically acceptable (LPTA) basis considering distribution fees for brand/generic and specialty pharmaceuticals. The total estimated value for all regions, including options, is $30.3 billion.
Task orders
Show 40 more
Latest 50 of 913 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D3003?
SPE2DR25D3003 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR25D3003 worth?
Orders under SPE2DR25D3003 have obligated $7,196,235. SPE2DR25D3003's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D3003?
913 orders have been placed under SPE2DR25D3003, the latest on July 24, 2026.
Who can order from contract SPE2DR25D3003?
SPE2DR25D3003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D3003 competed?
The extent of competition for SPE2DR25D3003 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV